Gliotoxin Derivative

Optimal result: 0 – 0.5 ppb

Aspergillus fumigatus produces the immunosuppressive agent Gliotoxin. Gliotoxin is a well studied mold toxin and has long been fingered as the main chemical player contributing to the virulence of A. fumigatus. 

Gliotoxin is hypothesized to be an important virulence factor in Aspergillus fumigatus. Experiments have demonstrated that gliotoxin is isolated in the highest concentrations from Aspergillus fumigatus in comparison to other Aspergillus species. This species of fungi is the most common cause of aspergillosis in humans. Gliotoxin is also the only toxin that has been isolated from the sera of patients suffering from invasive aspergillosis. These results suggest a link between gliotoxin secretion and fungal pathogenicity.

Exposure to fungal species that secrete gliotoxin is common because airborne Aspergillus fungal spores are ubiquitous in many environments. Regular environmental exposure does not typically cause illness, but can cause serious infections in immunosuppressed individuals or those suffering from chronic respiratory illnesses. Infections caused by Aspergillus fungus are called aspergillosis. There are many types of aspergillosis, but infections typically affect the lungs or the sinuses.

While not enough data exists to definitively tie chronic gliotoxin exposure to the development of cancer, chronic exposure to other immunosuppressive agents has been linked to the development of lymphomas and mammary tumors. Individuals taking immunosuppressive medications or with previous or current exposure to chemotherapy radiation are at higher risk for the development of these tumors.

The treatment approach should include:

- Educational counseling regarding environmental control and incitant avoidance.

- Neutralization antigen therapy for molds and mycotoxins for increased tolerance and effective mycotoxin detoxification.

- Intravenous and oral supplement nutrition therapy.

- Immunotherapy

- Deep heat depuration therapy (sauna detoxification).

How to inspect one's environment?

Molds and mycotoxins have been increasingly associated with illnesses due to faulty construction, water leaks, floods, and other forms of moisture accumulation that allow them to grow indoors. Visual and odor inspections, as well as spore counts and culture plates, can be used to determine the level of contamination in a building.

Gliotoxin: What It Is and What Your Test Results Mean

What is gliotoxin?
Gliotoxin is a toxic secondary metabolite (mycotoxin) produced by several fungal species, including Aspergillus, Candida, Eurotium, Trichoderma, Neosartorya, Penicillium, and Acremonium. It is most commonly associated with Aspergillus fumigatus, A. flavus, and A. niger—fungi known for causing invasive infections, particularly in individuals with weakened immune systems.

How Does Gliotoxin Exposure Occur?

  • Inhalation or environmental exposure: Mold-contaminated indoor environments can release airborne spores that contain gliotoxin.

  • Ingestion: Gliotoxin may be present in contaminated food, especially in poorly stored grains, nuts, and spices.

  • Fungal infection: Gliotoxin is produced internally during active fungal infections, particularly in immunocompromised individuals.

Health Effects of Gliotoxin

Gliotoxin is harmful due to its:

  • Immunosuppressive properties, weakening the body’s ability to fight infections

  • Genotoxicity, meaning it can damage DNA

  • Role in fungal pathogenicity, helping fungi evade immune responses and spread within the host

In clinical settings, gliotoxin-producing fungi have been detected in the bloodstream of patients with compromised immunity, such as those undergoing chemotherapy, organ transplants, or living with HIV/AIDS.


What does an EQUIVOCAL Gliotoxin test result mean?

An equivocal result means the level of gliotoxin detected is inconclusive—neither clearly positive nor negative. This result typically indicates that the gliotoxin concentration is near the test's threshold for detection and may be influenced by:

  • Mild or transient exposure

  • Early-stage fungal colonization

  • Laboratory variability or sample quality issues

What to do if your gliotoxin result is equivocal:

  • Retest: A follow-up test can help determine whether the exposure is increasing, decreasing, or resolving.

  • Evaluate symptoms and risk: Discuss any signs of fungal infection or immune compromise with your healthcare provider.

  • Environmental assessment: Consider testing your home or workplace for mold if environmental exposure is suspected.

  • Support detoxification: Some approaches to support clearance of mycotoxins include optimizing liver function, ensuring proper hydration, and using binders or antioxidants under clinical guidance.

Fungal toxins are considered secondary metabolites which may provide selective advantage under particular conditons.

Gliotoxin belongs to the epipolythiodioxopiperazine class of secondary metabolites (=ETPs). 

The ETPs are produced by a wide variety of fungi, e.g., Aspergillus spp, Chaetomium spp, Penicillium spp, to mention a few. However, Gliotoxin produced by Aspergillus fumigatus has received wide attention because it is considered a virulence factor for A. fumigatus, as well as being present in the sera of cancer patients with aspergillosis (Sugui et al, 2007; Sugui et al, 2007; Bok et al, 2006).

Gliotoxin has been detected in the lung tissue and sera of mice with invasive aspergillosis and sera of cancer patients (Lewis et al, 2005a). The percentage of Aspergillus isolates from cancer patients produced gliotoxin as follows: fumigatus (93 %), niger (75 %), terreus (25 %) and flavus (4 %). (Lewis et al, 2005b). However, only 18 % of A. fumigatus in European patients produce gliotoxin, while 23 % of A. flavus isolates produced aflatoxin B1 (Kosalec and Pepeljnjak, 2005). The difference between the two reports may result from differences in strains of A. fumigatus in culture media and temperature (Kosalec et al, 2005).

The pathobiology of gliotoxin is multi-faceted (Kwon-Chung and Sugui, 2009). These are: 1) the S-S group in the ring forms adducts with cysteine residues of proteins; 2) The S-S group readily goes through a redox cycle production reactive oxygen species (ROS); 3) gliotoxin is immunosuppressive inhibiting phagocytosis; blocking NF-kB transcription factor, inhibiting proinflammatory response and cytokine production; 4) causes mitochondrial directed apoptosis ; 5) induces PM-mediated inflammation in organ transplant patients treated with corticosteroids.; and 6) the mycotoxin probably inhibits normal neutrophil functions in healthy subjects.

Finally, it was believed that gliotoxin was produced by the yeast Candida albicans. However, this observation has recently been questioned (Kupfahl et al 2007).

In conclusion, several species of Aspergillus and other fungi, as well as possibly yeast, produced gliotoxin both in vitro and in vivo. More attention should be paid to this mycotoxin because of its multi-faceted toxic properties.

What is Aspergillus?

Aspergillus spreads in the environment by releasing conidia which are capable of infiltrating the small alveolar airways of individuals. 

In order to evade the body’s defenses Aspergillus releases Gliotoxin to inhibit the immune system (=prevent the immune system from reacting). 

- Gliotoxin impairs the activation of T-cells. T-Cells are immune cells that protect the body from pathogens. 

- Gliotoxin also induces apoptosis (=a form of programmed cell death) in monocytes (=a type of white blood cell) and in monocyte-derived dendritic cells (=T-cell helpers). 

These impairments can lead to multiple neurological syndromes.

What is Invasive Aspergillosis?

Aspergillus fumigatus is responsible for a life-threatening systemic disease called “invasive aspergillosis” (IA) in immunocompromised individuals where mold actually grows inside the lungs but can invade other areas as well. Insufficient immune defense mechanisms result in high IA mortality rates in neutropenic (low white blood cell count) and immunosuppressed patients. 

Connection to Multiple Sclerosis:

Recent research has implicated the mold produced immunosuppressive Gliotoxin as a likely cause of Multiple Sclerosis in people that have a genetic disposition for MS. The frequency of MS has been increasing. [L]

What is the standard treatment for mycotoxins in humans?

1. There is not a generally accepted “standard treatment.” There are many protocols developed by individual doctors who specialize in mold and mycotoxin associated illnesses. These include FIR Sauna, Glutathione, use of sequestering agents such as Cholestyramine or charcoal, antioxidants, probiotics, and intra-nasal anti-fungal treatments. 
2. It is important to note that avoidance is the most important criteria. Leave the dwelling where you are being exposed until it is inspected by an Environmental Inspector and if necessary, remediated.

References:

http://www.ncbi.nlm.nih.gov/pubmed/19843884

http://www.ncbi.nlm.nih.gov/pubmed/17030582

http://www.ncbi.nlm.nih.gov/pubmed/20645385

http://www.ncbi.nlm.nih.gov/pubmed/15817772

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2729542/

http://www.ncbi.nlm.nih.gov/pubmed/8777967

http://www.ncbi.nlm.nih.gov/pubmed/8666939

http://www.ncbi.nlm.nih.gov/pubmed/17626149

https://www.clinicaltherapeutics.com/article/S0149-2918(18)30189-9/pdf

https://globaljournals.org/GJMR_Volume14/1-Family-of-Six-their-Health.pdf

Gliotoxin Derivative
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Gliotoxin Derivative — 10,000+ markers explained
One Gliotoxin Derivative result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro